Parametric Portfolio Associates’s Trillium Therapeutics Inc. TRIL Stock Holding History

Parametric Portfolio Associates’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-109,415	Closed	-$1.92M	–	3752
2021 Q3	$1.92M	Buy	109,415 +85,261	+353%	+$996K	﹤0.01%	2462
2021 Q2	$234K	Buy	+24,154	New	+$227K	﹤0.01%	3351

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Parametric Portfolio Associates's TRIL Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 109,415 shares — an estimated $1.92M sold.

Parametric Portfolio Associates first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $1.92M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Parametric Portfolio Associates reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 109,415 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.92M.
Parametric Portfolio Associates first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
Parametric Portfolio Associates's Trillium Therapeutics Inc. position peaked at $1.92M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.